Skip to main content
Erschienen in: Digestive Diseases and Sciences 9/2016

23.04.2016 | Original Article

Does Low Threshold Value Use Improve Proximal Neoplasia Detection by Fecal Immunochemical Test?

verfasst von: Nam Hee Kim, Hyo-Joon Yang, Soo-Kyung Park, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung

Erschienen in: Digestive Diseases and Sciences | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Several studies have reported that the fecal immunochemical test (FIT) less sensitively detects proximal advanced neoplasia (AN) compared to distal AN. Low threshold value use may improve proximal AN detection.

Aim

To investigate whether FIT diagnostic accuracy for AN is different according to AN location and to compare FIT accuracy in proximal AN detection using different threshold values.

Methods

This retrospective study was conducted in a university hospital in Korea from June 2013 to May 2015. Out of 34,547 participants who underwent FITs, 3990 subjects aged ≥50 years who also underwent colonoscopies were analyzed. The FIT diagnostic accuracy for AN with differing locations (proximal vs. distal) and threshold values (20, 15, and 10 mcg Hb/g feces) were assessed.

Results

The sensitivity, specificity, positive predictive value, and negative predictive value of FIT in AN detection were 42.2, 84.3, 24.1, and 92.5 %, respectively. The FIT sensitivity for proximal AN detection was significantly lower than that for distal AN detection (32.7 and 49.0 %, respectively; P = 0.001). Lowering FIT threshold values tended to increase the sensitivity for proximal AN, whereas it significantly decreased the specificity for proximal AN. As a result, there was no significant difference in the accuracy for proximal AN detection (80.1, 79.3, and 78.1 % for 20, 15, and 10 mcg Hb/g feces, respectively; P = 0.107).

Conclusions

FIT was less sensitive in proximal AN detection than distal AN detection. Lowering the FIT cutoff threshold did not increase the accuracy for proximal AN detection. New biomarker development for colorectal cancer screening is required to improve proximal ACRN diagnostic accuracy.
Literatur
1.
Zurück zum Zitat Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917.CrossRefPubMed Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917.CrossRefPubMed
2.
5.
Zurück zum Zitat Smith RA, Andrews K, Brooks D, et al. Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2016;66:95–114.CrossRef Smith RA, Andrews K, Brooks D, et al. Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2016;66:95–114.CrossRef
7.
Zurück zum Zitat Carroll MR, Seaman HE, Halloran SP. Tests and investigations for colorectal cancer screening. Clin Biochem. 2014;47:921–939.CrossRefPubMed Carroll MR, Seaman HE, Halloran SP. Tests and investigations for colorectal cancer screening. Clin Biochem. 2014;47:921–939.CrossRefPubMed
8.
Zurück zum Zitat Young GP, Symonds EL, Allison JE, et al. Advances in fecal occult blood tests: the FIT revolution. Dig Dis Sci. 2015;60:609–622.CrossRefPubMed Young GP, Symonds EL, Allison JE, et al. Advances in fecal occult blood tests: the FIT revolution. Dig Dis Sci. 2015;60:609–622.CrossRefPubMed
9.
Zurück zum Zitat Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012;366:697–706.CrossRefPubMed Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012;366:697–706.CrossRefPubMed
10.
Zurück zum Zitat Chen LS, Yen AM, Chiu SY, et al. Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort. Lancet Oncol. 2011;12:551–558.CrossRefPubMed Chen LS, Yen AM, Chiu SY, et al. Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort. Lancet Oncol. 2011;12:551–558.CrossRefPubMed
11.
Zurück zum Zitat Stegeman I, de Wijkerslooth TR, Mallant-Hent RC, et al. Implementation of population screening for colorectal cancer by repeated fecal immunochemical test (FIT): third round. BMC Gastroenterol. 2012;12:73.CrossRefPubMedPubMedCentral Stegeman I, de Wijkerslooth TR, Mallant-Hent RC, et al. Implementation of population screening for colorectal cancer by repeated fecal immunochemical test (FIT): third round. BMC Gastroenterol. 2012;12:73.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Yoo KY. Cancer control activities in the Republic of Korea. Jpn J Clin Oncol. 2008;38:327–333.CrossRefPubMed Yoo KY. Cancer control activities in the Republic of Korea. Jpn J Clin Oncol. 2008;38:327–333.CrossRefPubMed
13.
Zurück zum Zitat de Wijkerslooth TR, Stoop EM, Bossuyt PM, et al. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol. 2012;107:1570–1578.CrossRefPubMed de Wijkerslooth TR, Stoop EM, Bossuyt PM, et al. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol. 2012;107:1570–1578.CrossRefPubMed
14.
Zurück zum Zitat Haug U, Kuntz KM, Knudsen AB, et al. Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia. Br J Cancer. 2011;104:1779–1785.CrossRefPubMedPubMedCentral Haug U, Kuntz KM, Knudsen AB, et al. Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia. Br J Cancer. 2011;104:1779–1785.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Wong MC, Ching JY, Chan VC, et al. Diagnostic accuracy of a qualitative fecal immunochemical test varies with location of neoplasia but not number of specimens. Clin Gastroenterol Hepatol. 2015;13:1472–1479.CrossRefPubMed Wong MC, Ching JY, Chan VC, et al. Diagnostic accuracy of a qualitative fecal immunochemical test varies with location of neoplasia but not number of specimens. Clin Gastroenterol Hepatol. 2015;13:1472–1479.CrossRefPubMed
16.
Zurück zum Zitat Morikawa T, Kato J, Yamaji Y, et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005;129:422–428.CrossRefPubMed Morikawa T, Kato J, Yamaji Y, et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005;129:422–428.CrossRefPubMed
17.
Zurück zum Zitat Cubiella J, Castro I, Hernandez V, et al. Characteristics of adenomas detected by fecal immunochemical test in colorectal cancer screening. Cancer Epidemiol Biomarkers Prev. 2014;23:1884–1892.CrossRefPubMed Cubiella J, Castro I, Hernandez V, et al. Characteristics of adenomas detected by fecal immunochemical test in colorectal cancer screening. Cancer Epidemiol Biomarkers Prev. 2014;23:1884–1892.CrossRefPubMed
18.
Zurück zum Zitat Chiu HM, Lee YC, Tu CH, et al. Association between early stage colon neoplasms and false-negative results from the fecal immunochemical test. Clin Gastroenterol Hepatol. 2013;11:832-838.e831–832-838.e832-838.e832-838.e832. Chiu HM, Lee YC, Tu CH, et al. Association between early stage colon neoplasms and false-negative results from the fecal immunochemical test. Clin Gastroenterol Hepatol. 2013;11:832-838.e831–832-838.e832-838.e832-838.e832.
19.
Zurück zum Zitat Wu D, Luo HQ, Zhou WX, et al. The performance of three-sample qualitative immunochemical fecal test to detect colorectal adenoma and cancer in gastrointestinal outpatients: an observational study. PLoS ONE. 2014;9:e106648.CrossRefPubMedPubMedCentral Wu D, Luo HQ, Zhou WX, et al. The performance of three-sample qualitative immunochemical fecal test to detect colorectal adenoma and cancer in gastrointestinal outpatients: an observational study. PLoS ONE. 2014;9:e106648.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Saito H. Screening for colorectal cancer by immunochemical fecal occult blood testing. Jpn J Cancer Res. 1996;87:1011–1024.CrossRefPubMed Saito H. Screening for colorectal cancer by immunochemical fecal occult blood testing. Jpn J Cancer Res. 1996;87:1011–1024.CrossRefPubMed
22.
Zurück zum Zitat Fraser CG, Allison JE, Halloran SP, et al. A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin. J Natl Cancer Inst. 2012;104:810–814.CrossRefPubMed Fraser CG, Allison JE, Halloran SP, et al. A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin. J Natl Cancer Inst. 2012;104:810–814.CrossRefPubMed
23.
Zurück zum Zitat Lai EJ, Calderwood AH, Doros G, et al. The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research. Gastrointest Endosc. 2009;69:620–625.CrossRefPubMedPubMedCentral Lai EJ, Calderwood AH, Doros G, et al. The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research. Gastrointest Endosc. 2009;69:620–625.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143:844–857.CrossRefPubMed Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143:844–857.CrossRefPubMed
25.
Zurück zum Zitat Cha JM, Kozarek RA, La Selva D, et al. Disparities in prevalence, location, and shape characteristics of colorectal neoplasia between South Korean and US patients. Gastrointest Endosc. 2015;82:1080–1086.CrossRefPubMed Cha JM, Kozarek RA, La Selva D, et al. Disparities in prevalence, location, and shape characteristics of colorectal neoplasia between South Korean and US patients. Gastrointest Endosc. 2015;82:1080–1086.CrossRefPubMed
26.
Zurück zum Zitat Soon MS, Kozarek RA, Ayub K, et al. Screening colonoscopy in Chinese and Western patients: a comparative study. Am J Gastroenterol. 2005;100:2749–2755.CrossRefPubMed Soon MS, Kozarek RA, Ayub K, et al. Screening colonoscopy in Chinese and Western patients: a comparative study. Am J Gastroenterol. 2005;100:2749–2755.CrossRefPubMed
27.
Zurück zum Zitat Lee HS, Jeon SW. Is retroflexion helpful in detecting adenomas in the right colon? A single center interim analysis. Intest Res. 2015;13:326–331.CrossRefPubMedPubMedCentral Lee HS, Jeon SW. Is retroflexion helpful in detecting adenomas in the right colon? A single center interim analysis. Intest Res. 2015;13:326–331.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Cha JM, Lee JI, Joo KR, et al. Use of a low cut-off value for the fecal immunochemical test enables better detection of proximal neoplasia. Dig Dis Sci. 2013;58:3256–3262.CrossRefPubMed Cha JM, Lee JI, Joo KR, et al. Use of a low cut-off value for the fecal immunochemical test enables better detection of proximal neoplasia. Dig Dis Sci. 2013;58:3256–3262.CrossRefPubMed
29.
Zurück zum Zitat Lee JK, Liles EG, Bent S, et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160:171.CrossRefPubMedPubMedCentral Lee JK, Liles EG, Bent S, et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160:171.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Friis S, Riis AH, Erichsen R, et al. Low-dose aspirin or nonsteroidal anti-inflammatory drug use and colorectal cancer risk: a population-based, case–control study. Ann Intern Med. 2015;163:347–355.CrossRefPubMed Friis S, Riis AH, Erichsen R, et al. Low-dose aspirin or nonsteroidal anti-inflammatory drug use and colorectal cancer risk: a population-based, case–control study. Ann Intern Med. 2015;163:347–355.CrossRefPubMed
31.
Zurück zum Zitat Nan H, Hutter CM, Lin Y, et al. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. JAMA. 2015;313:1133–1142.CrossRefPubMedPubMedCentral Nan H, Hutter CM, Lin Y, et al. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. JAMA. 2015;313:1133–1142.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Brenner H, Tao S, Haug U. Low-dose aspirin use and performance of immunochemical fecal occult blood tests. JAMA. 2010;304:2513–2520.CrossRefPubMed Brenner H, Tao S, Haug U. Low-dose aspirin use and performance of immunochemical fecal occult blood tests. JAMA. 2010;304:2513–2520.CrossRefPubMed
33.
Zurück zum Zitat Chubak J, Bogart A, Fuller S, et al. Uptake and positive predictive value of fecal occult blood tests: a randomized controlled trial. Prev Med. 2013;57:671–678.CrossRefPubMed Chubak J, Bogart A, Fuller S, et al. Uptake and positive predictive value of fecal occult blood tests: a randomized controlled trial. Prev Med. 2013;57:671–678.CrossRefPubMed
34.
Zurück zum Zitat Park DI, Ryu S, Kim YH, et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol. 2010;105:2017–2025.CrossRefPubMed Park DI, Ryu S, Kim YH, et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol. 2010;105:2017–2025.CrossRefPubMed
35.
Zurück zum Zitat van Roon AH, Wilschut JA, Hol L, et al. Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance. Clin Gastroenterol Hepatol. 2011;9:333–339.CrossRefPubMed van Roon AH, Wilschut JA, Hol L, et al. Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance. Clin Gastroenterol Hepatol. 2011;9:333–339.CrossRefPubMed
Metadaten
Titel
Does Low Threshold Value Use Improve Proximal Neoplasia Detection by Fecal Immunochemical Test?
verfasst von
Nam Hee Kim
Hyo-Joon Yang
Soo-Kyung Park
Jung Ho Park
Dong Il Park
Chong Il Sohn
Kyuyong Choi
Yoon Suk Jung
Publikationsdatum
23.04.2016
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 9/2016
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4169-3

Weitere Artikel der Ausgabe 9/2016

Digestive Diseases and Sciences 9/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.